{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:18:36Z","timestamp":1726442316919},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T00:00:00Z","timestamp":1401667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-297","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T15:16:39Z","timestamp":1401722199000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Do the omeprazole family compounds exert a protective effect against influenza-like illness?"],"prefix":"10.1186","volume":"14","author":[{"given":"Roberto","family":"Gasparini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero Luigi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Trucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Boccalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Cristina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Amicizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Panatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,2]]},"reference":[{"key":"3601_CR1","volume-title":"State of the art of new vaccines: research and development","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: State of the art of new vaccines: research and development. 2006, Geneva, Switzerland: World Health Organization Document Production Services, [Available at: http:\/\/www.path.org\/vaccineresources\/files\/New_vaccines_rsch_dev.pdf ] Accessed on June 5, 2014"},{"key":"3601_CR2","unstructured":"Center for Diseases Control (CDC): Seasonal Influenza-Associated Hospitalizations in the United States. [Available at: http:\/\/www.cdc.gov\/flu\/about\/qa\/hospital.htm ] Accessed on July 15, 2011"},{"issue":"Supp","key":"3601_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4161\/hv.7.0.14607","volume":"7","author":"PL Lai","year":"2011","unstructured":"Lai PL, Panatto D, Ansaldi F, Canepa P, Amicizia D, Patria AG, Gasparini R: Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A\/California\/07\/09) pandemic. Hum Vaccin. 2011, 7 (Supp): 217-225.","journal-title":"Hum Vaccin"},{"key":"3601_CR4","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","volume":"25","author":"NA Molinari","year":"2007","unstructured":"Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB: The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007, 25: 5086-5096. 10.1016\/j.vaccine.2007.03.046.","journal-title":"Vaccine"},{"key":"3601_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3201\/eid1201.051068","volume":"12","author":"AS Monto","year":"2006","unstructured":"Monto AS: Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis. 2006, 12: 55-60. 10.3201\/eid1201.051068.","journal-title":"Emerg Infect Dis"},{"key":"3601_CR6","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/JVI.67.9.5585-5594.1993","volume":"67","author":"C Wang","year":"1993","unstructured":"Wang C, Takeuchi K, Pinto LH, Lamb RA: Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol. 1993, 67: 5585-5594.","journal-title":"J Virol"},{"key":"3601_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1086\/314994","volume":"180","author":"T Ziegler","year":"1999","unstructured":"Ziegler T, Hemphill ML, Ziegler ML, Perez-Oronoz G, Klimov AI, Hampson AW, Regnery HL, Cox NJ: Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis. 1999, 180: 935-939. 10.1086\/314994.","journal-title":"J Infect Dis"},{"key":"3601_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","volume":"366","author":"RA Bright","year":"2005","unstructured":"Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI: Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005, 366: 1175-1181. 10.1016\/S0140-6736(05)67338-2.","journal-title":"Lancet"},{"key":"3601_CR9","unstructured":"World Health Organization Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses Revised February 2010 Part I: Recommendations Pharmacological Management of Pandemic Influenza A (H1N1) 2009 Part I: Recommendations. [Available at: http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/h1n1_guidelines_pharmaceutical_mngt.pdf .] Accessed on July 15, 2011"},{"key":"3601_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004, 364: 759-765. 10.1016\/S0140-6736(04)16934-1.","journal-title":"Lancet"},{"key":"3601_CR11","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","volume":"50","author":"MP Malakhov","year":"2006","unstructured":"Malakhov MP, Aschenbrenner LM, Smee DF, Wandersee MK, Sidwell RW, Gubareva LV, Mishin VP, Hayden FG, Kim DH, Ing A, Campbell ER, Yu M, Fang F: Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother. 2006, 50: 1470-1479. 10.1128\/AAC.50.4.1470-1479.2006.","journal-title":"Antimicrob Agents Chemother"},{"key":"3601_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1743-422X-3-39","volume":"3","author":"EE Ooi","year":"2006","unstructured":"Ooi EE, Chew JS, Loh JP, Chua RC: In vitro inhibition of human influenza A virus replication by chloroquine. Virol J. 2006, 3: 39-10.1186\/1743-422X-3-39.","journal-title":"Virol J"},{"key":"3601_CR13","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2165\/11537960-000000000-00000","volume":"70","author":"DA Boltz","year":"2010","unstructured":"Boltz DA, Aldridge JR, Webster RG, Govorkova EA: Drugs in development for influenza. Drugs. 2010, 70: 1349-1362. 10.2165\/11537960-000000000-00000.","journal-title":"Drugs"},{"key":"3601_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/eri.11.112","volume":"9","author":"H Ikematsu","year":"2011","unstructured":"Ikematsu H, Kawai N: Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev Anti Infect Ther. 2011, 9: 851-857. 10.1586\/eri.11.112.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3601_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1124\/jpet.109.162149","volume":"333","author":"M Yamaya","year":"2010","unstructured":"Yamaya M, Shinya K, Hatachi Y, Kubo H, Asada M, Yasuda H, Nishimura H, Nagatomi R: Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial Cells. J Pharmacol Exp Ther. 2010, 333: 81-90. 10.1124\/jpet.109.162149.","journal-title":"J Pharmacol Exp Ther"},{"key":"3601_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3851\/IMP2064","volume":"17","author":"JP DeVincenzo","year":"2012","unstructured":"DeVincenzo JP: The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses. Antivir Ther. 2012, 17: 213-225. 10.3851\/IMP2064.","journal-title":"Antivir Ther"},{"key":"3601_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.39105.428981.BE","volume":"334","author":"S Tsiodras","year":"2007","unstructured":"Tsiodras S, Mooney JD, Hatzakis A: Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ. 2007, 334: 293-294. 10.1136\/bmj.39105.428981.BE.","journal-title":"BMJ"},{"key":"3601_CR18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.vaccine.2011.12.014","volume":"30","author":"G Carraro","year":"2012","unstructured":"Carraro G, Naso A, Montomoli E, Gasparini R, Camerini R, Panatto D, Tineo MC, De Giorgi L, Piccirella S, Khadang B, Ceracchi M, De Rosa A: Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study. Vaccine. 2012, 30: 1170-1180. 10.1016\/j.vaccine.2011.12.014.","journal-title":"Vaccine"},{"key":"3601_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","volume":"14","author":"CAM Stedman","year":"2000","unstructured":"Stedman CAM, Barclay ML: Review article: comparison of pharmacokinetics acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther. 2000, 14: 963-978. 10.1046\/j.1365-2036.2000.00788.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"3601_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejphar.2004.12.042","volume":"509","author":"T Sasaki","year":"2005","unstructured":"Sasaki T, Yamaya M, Yasuda H, Inoue D, Yamada M, Kubo H, Nishimura H, Sasaki H: The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. Eur J Pharmacol. 2005, 509: 201-210. 10.1016\/j.ejphar.2004.12.042.","journal-title":"Eur J Pharmacol"},{"key":"3601_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","volume":"40","author":"RA Lamb","year":"1985","unstructured":"Lamb RA, Zebedee SL, Richardson CD: Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 1985, 40: 627-633. 10.1016\/0092-8674(85)90211-9.","journal-title":"Cell"},{"key":"3601_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0140-6736(02)07605-5","volume":"359","author":"FK Schulz","year":"2002","unstructured":"Schulz FK, Grimes DA: Case-control studies: research in reverse. Lancet. 2002, 359: 431-434. 10.1016\/S0140-6736(02)07605-5.","journal-title":"Lancet"},{"key":"3601_CR23","unstructured":"Influenza-like illness case definition. [Available at: http:\/\/www.acha.org\/ILI_Project\/ILI_case_definition_CDC.pdf .] Accessed on September 3, 2011"},{"key":"3601_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1086\/317425","volume":"31","author":"G Boivin","year":"2000","unstructured":"Boivin G, Hardy I, Tellier G, Maziade J: Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000, 31: 1166-1169. 10.1086\/317425.","journal-title":"Clin Infect Dis"},{"key":"3601_CR25","unstructured":"INFLUNET \u2013 Italian Influenza Surveillance Network. [Available at: http:\/\/www.salute.gov.it\/portale\/temi\/p2_5.jsp?lingua=italiano&area=influenza&menu=sorveglianza ] Accessed on June 5, 2014"},{"key":"3601_CR26","unstructured":"Decreto Legislativo 30 giugno 2003, n. 196 \"Codice in materia di protezione dei dati personali\". Gazzetta Ufficiale n. 174 del 29 luglio 2003 - Supplemento Ordinario n. 123. [Available at: http:\/\/www.camera.it\/parlam\/leggi\/deleghe\/03196dl.htm ] Accessed on June 5, 2014"},{"key":"3601_CR27","unstructured":"International Statistical Classification of Diseases and Related Health Problems 10th Revision [ICD-10]. [Available at: http:\/\/www.who.int\/classifications\/icd\/en\/ ] Accessed on June 5, 2014"},{"key":"3601_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/ije\/26.1.224","volume":"26","author":"CG Victora","year":"1997","unstructured":"Victora CG, Huttly SR, Fuchs SC, Olinto MT: The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol. 1997, 26: 224-227. 10.1093\/ije\/26.1.224.","journal-title":"Int J Epidemiol"},{"key":"3601_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.aje.a112793","volume":"110","author":"WJ Blot","year":"1979","unstructured":"Blot WJ, Day NE: Synergism and interaction: are they equivalent?. Am J Epidemiol. 1979, 110: 99-100.","journal-title":"Am J Epidemiol"},{"key":"3601_CR30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/oxfordjournals.aje.a113014","volume":"112","author":"R Saracci","year":"1980","unstructured":"Saracci R: Interaction and synergism. Am J Epidemiol. 1980, 112: 465-466.","journal-title":"Am J Epidemiol"},{"key":"3601_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10654-011-9554-9","volume":"26","author":"MJ Knol","year":"2011","unstructured":"Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE: Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol. 2011, 26: 433-438. 10.1007\/s10654-011-9554-9.","journal-title":"Eur J Epidemiol"},{"key":"3601_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ije\/dyr218","volume":"41","author":"MJ Knol","year":"2012","unstructured":"Knol MJ, VanderWeele TJ: Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012, 41: 514-520. 10.1093\/ije\/dyr218.","journal-title":"Int J Epidemiol"},{"key":"3601_CR33","doi-asserted-by":"publisher","first-page":"c158","DOI":"10.1159\/000327598","volume":"119","author":"DJ de Jager","year":"2011","unstructured":"de Jager DJ, de Mutsert R, Jager KJ, Zoccali C, Dekker FW: Reporting of interaction. Nephron Clin Pract. 2011, 119: c158-c161. 10.1159\/000327598.","journal-title":"Nephron Clin Pract"},{"key":"3601_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","volume":"20","author":"T Andersson","year":"2005","unstructured":"Andersson T, Alfredsson L, K\u00e4llberg H, Zdravkovic S, Ahlbom A: Calculating measures of biological interaction. Eur J Epidemiol. 2005, 20: 575-579. 10.1007\/s10654-005-7835-x.","journal-title":"Eur J Epidemiol"},{"key":"3601_CR35","first-page":"339","volume":"41","author":"KW Chang","year":"2000","unstructured":"Chang KW, Lin SJ, Hsueh C, Kong MS: Menetrier\u2019s disease associated with cytomegalovirus infection in a child. Acta Paediatr Taiwan. 2000, 41: 339-340.","journal-title":"Acta Paediatr Taiwan"},{"key":"3601_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/MMBR.00016-08","volume":"72","author":"S Hong","year":"2008","unstructured":"Hong S, Pedersen PL: ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiol Mol Biol Rev. 2008, 72: 590-641. 10.1128\/MMBR.00016-08.","journal-title":"Microbiol Mol Biol Rev"},{"key":"3601_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1039\/b517734k","volume":"5","author":"LH Pinto","year":"2006","unstructured":"Pinto LH, Lamb RA: Influenza virus proton channels. Photochem Photobiol Sci. 2006, 5: 629-632. 10.1039\/b517734k.","journal-title":"Photochem Photobiol Sci"},{"key":"3601_CR38","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1128\/JVI.68.9.5882-5889.1994","volume":"68","author":"JM Casasnovas","year":"1994","unstructured":"Casasnovas JM, Springer TA: Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J Virol. 1994, 68: 5882-5889.","journal-title":"J Virol"},{"key":"3601_CR39","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","volume":"292","author":"RJ Laheij","year":"2004","unstructured":"Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB: Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004, 292: 1955-1960. 10.1001\/jama.292.16.1955.","journal-title":"JAMA"},{"key":"3601_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/thx.2006.062885","volume":"61","author":"EM van de Garde","year":"2006","unstructured":"van de Garde EM, Hak E, Souverein PC, Hoes AW, van den Bosch JM, Leufkens HG: Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax. 2006, 61: 957-961. 10.1136\/thx.2006.062885.","journal-title":"Thorax"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-297\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:36:21Z","timestamp":1597926981000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3601"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-297","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2014,6,2]]},"assertion":[{"value":"11 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"297"}}